New Frontier Medicine (06108.HK) plans to participate in investment and construction of a health industry park in Shengzhou, Zhejiang Province.

Wisdom Financial News APP, the emerging pharmaceutical company New Frontier (06108.HK) announced that on August 12, 2025, the company's indirectly wholly-owned subsidiary China New Frontier, partner A Hong Kong New Frontier Wanma Health Industry Co., Ltd., and partner B Yiheng Technology Development Hong Kong Co., Ltd. entered into a cooperation agreement regarding (including) capital injection into the target company and the operation and management of the target company.